Dr. Natasia Marques

Natasia Marques is a researcher focused on the intersection of infectious diseases and oncology, with particular emphasis on HIV-associated malignancies. Her work explores how immune suppression driven by HIV infection contributes to cancer development, positioning her within the fields of molecular oncology, virology, and global health.

Her recent publication in Cancers examines the molecular mechanisms underlying AIDS-defining and non-AIDS-defining malignancies, including Kaposi sarcoma, invasive cervical cancer, and lymphoma. The analysis highlights the complex role of chronic immune activation, viral co-infections, and incomplete immune restoration despite antiretroviral therapy, underscoring the need for integrated therapeutic strategies.

Based on the limited publications currently available, her research demonstrates a strong emphasis on translational insight, bridging molecular pathways with clinical outcomes. The work contributes to a deeper understanding of cancer risk in immunocompromised populations and reinforces the importance of advancing both preventive and therapeutic approaches in HIV-related oncology.